Key result
Single catheter ablation achieves freedom from AF recurrence in ~39% of patients with HCM.
Why the study?
Limited data exist about the efficacy and clinical outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
Meta-Analysis (n=1,183)
Effect estimate: 39% (95% CI 35-44)
Supports cautious ablation expectations in HCM; extends meta-analytic data while leaving open need for optimized strategies and RCTs.
Background Atrial fibrillation (AF) is the most common arrhythmia in patients with hypertrophic cardiomyopathy (HCM). Limited data exists about the efficacy and clinical outcomes of AF ablation in HCM. Objective The purpose of this meta-analysis was to evaluate the role of catheter-based ablation for treatment of AF in patients with HCM. Methods PubMed, SCOPUS, Web of Science, Embase, Cochrane library, and ClinicalTrials.gov were searched for studies discussing outcomes of catheter-based ablation for AF in patients with HCM. Two reviewers independently screened studies and extracted relevant data. Incidence rate estimates from individual studies underwent logit transformation to calculate the weighted summary proportion under the random effect model. Results A total of 19 reports met the inclusion criteria (1183 patients). The single ablation procedure was successful in 39% patients. Up to 34% patients underwent a repeat ablation. About 41% patients in normal sinus rhythm after successful AF ablation received postprocedure antiarrhythmic drug (AAD) therapy. Patients undergoing successful AF ablation experienced a significant improvement in the New York Heart Association functional class (standardized mean difference –1.03; 95% confidence interval –1.23 to –0.83; P < .00001). Conclusion AF ablation appears to be safe and feasible in patients with HCM. Freedom from AF after undergoing successful ablation is associated with significant improvement in heart failure symptoms.
No takes yet. Share an insight, caveat, or question.
Latif et al. (2023) conducted a meta-analysis in Atrial fibrillation in hypertrophic cardiomyopathy (n=1,183). Catheter ablation was evaluated on Freedom from atrial fibrillation recurrence after single ablation (39%, 95% CI 35-44). In a meta-analysis of patients with hypertrophic cardiomyopathy, a single catheter ablation procedure achieved freedom from atrial fibrillation recurrence in 39% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: